Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Advanced Enzymes announces Positive Clinical Breakthrough in the Randomized Controlled Trials of Systemic Enzymes and Probiotics to Resolve 'Long Covid' Fatigue Symptoms

Posted On: 2021-09-13 07:16:22 (Time Zone: UTC)


Advanced Enzyme Technologies Limited (AETL) (NSE: ADVENZYMES; BSE: 540025) today announced that its systemic enzyme and probiotic supplements-ImmunoSEB and ProbioSEB CSC3 have passed the promising stages of randomized controlled clinical trials in terms of efficacy to resolve post-COVID fatigue symptoms.

It's a fact that muscle fatigue and cognitive disturbances persist in patients after recovery from acute COVID-19 disease. However, there are no specific treatments available globally to treat post-COVID fatigue complications.

With an aim to evaluate the efficacy and safety of the health supplements ImmunoSEB (systemic enzyme complex) and ProbioSEB CSC3 (probiotic complex) in patients suffering from COVID-19 induced fatigue, a randomized, multi-centric, double blind and placebo-controlled trial was conducted in 200 patients suffering from post-COVID fatigue symptoms.

The test arm (100 patients) received the oral supplements for 14-days and the control arm (100 patients) received placebo, informed Dr. Abhijit K. Rathi, Principal Scientist, AETL.

The randomized clinical trial was conducted on 200 patients that did not have an active SARS-CoV-2 infection, as determined by a negative COVID-19 test, with a complaint of post-COVID fatigue. Patients were required to have a positive COVID-19 test at any time in the past. The trial was conducted across three centres in India-Swasthya Hospital, Bhopal; Samvedna Hospital, Varanasi; and Chirayu Medical College & Hospital, Bhopal by Investigators for 14-days, informed Dr Rathi.

According to the clinical research paper published by the Switzerland-based "Medicines" Journal on August 30, 2021, the treatment efficacy was compared using the Chalder Fatigue Scale (CFQ-11) for 14-days. Interestingly, the supplemental treatment resulted in resolution of fatigue in a greater percentage in patients during the test as against the control arm (91% vs. 15%) during the 14-day trial. Patients in the test arm category showed a significantly greater reduction the overall physical and mental fatigue scores as against patients in the control arm segment. The supplements were well tolerated with no adverse events reported. This clinical study demonstrated that the 14-day supplementation of ImmunoSEB and ProbioSEB CSC3 resolved post-COVID-19 fatigue symptoms and improved patients' functional status and quality of life, informed Dr. Rathi.

The Coronavirus disease-19 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a worldwide pandemic afflicting a large population across the globe. Most infected people develop acute symptoms that last for 7-10 days. However, one or more symptoms (physical, cognitive and/or psychological) persist for weeks or even months in a substantial percentage of people. Fatigue is the most persistent and debilitating symptom of long COVID.

Studies revealed that about 52 percent of patients among the studied population showed fatigue/myalgia post-COVID-19.

A survey done by the Office for National Statistics (ONS), United Kingdom suggests that about one in five people have symptoms of long COVID five weeks after an initial infection and one in ten after twelve weeks. The chronic phase of COVID-19 is conjectured to be perpetual, with impaired functional status and quality of life. Though the data on COVID fatigue is still emerging, viral infections are known to trigger chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME) in patients. There are no specific biomarkers, and diagnosis is typically based on symptoms.

"Enzymes and probiotics are a robust mechanism to revitalize stamina and vitality, which is proved during the recently concluded randomized clinical trials," said Mr. Vasant Rathi, Chairman, AETL.

"Recent trials suggest that nutraceuticals product supplement succours in recovery of COVID patients. However, the patient-oriented outcome of the supplement may vary in individuals. For some, they may find a difference within couple of days, but for others, it may take a week or ten days. To avail long-term benefit and better results of the supplement, it's advisable to take the immunity bundle doses consistently every day for couple of months. However, in case you miss the dosage, don't' worry as it has no side effects," said Mr. Rathi.

"We have served the Americans since over last 30 years. But during the pandemic, our key focus was to enhance immunity amongst Indians. Hence, we went online with our research-backed immunity bundle. I feel, doctors need to address the issue of post-COVID immunity soon as its affecting quality of life," said Mr. Mukund Kabra, Director, Advanced Enzyme Technologies Limited (AET).

To benefit common people our researched-backed chemical-free post-COVID immune support bundle - ImmunoSEB and Biome Ultra (ProbioSEB CSC3), our company has beefed up our omnichannel presence across India and globally. We tasted our runaway success in the US markets amidst the pandemic, hence decided to list our flagship immune support brands across online marketplaces in India to target a larger swath of pill-fatigued, healthy agers, immunity conscious millennials, and Gen Z, said Mr Kabra.

Meanwhile, the products are currently available globally on the leading e-commerce marketplace - Amazon. In a move to further shore up its direct-to-customer (D2C) omnichannel retailing business, AETL has unveil its online store - 'Advanced Enzymes e-Direct Store' in September 2021 to help customers choose from a wide range of health support products.

Shares of Advanced Enzyme Technologies Limited was last trading in BSE at Rs. 372.8 as compared to the previous close of Rs. 366.2. The total number of shares traded during the day was 11499 in over 735 trades.

The stock hit an intraday high of Rs. 375.55 and intraday low of 360. The net turnover during the day was Rs. 4236469.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

Anupam Rasayan signs LOI worth Rs 145 Cr with European Multinational Company

Quick Heal appoints global industry veteran Richard Stiennon to its Board

RBI imposes penalty of Rs. 2 crore on RBL Bank Ltd

Whirlpool India enters into agreements to acquire majority stake of Elica PB India

Indiabulls Housing Finance Ltd. raises ₹ 27 crores by selling part of its stake in OakNorth Holdings Ltd

Federal Bank launches RuPay Signet Contactless Credit Card

First procedure in Asia-Pacific performed with Medtronic Hugo™ robotic-assisted surgery system

Websol Energy System Ltd's Module approved by MNRE

Tata Steel join the Sea Cargo Charter to reduce 'Scope 3' greenhouse gas emissions in ocean trade

ICICI Bank to offer instant overdraft to sellers registered on amazon.in

ICRA upgrades rating of Jindal Steel and Power Ltd

Avi Products India Ltd board to consider preferential allotment on Oct 1, 2021

Raymond Board approves Business Consolidation

HDFC Bank allots 6.44% 2028 Bonds

Minor Fire at records storage room of Kovai Medical Center and Hospital Ltd

Whirlpool of India Ltd increases stake in Elica India

Praveg Communications India Limited wins award and recognition to Tent City Narmada at Kevadiya

Karur Vysya Bank donates Rs. 3.14 crores to PM CARES FUND under CSR

ICICI Prudential Life Insurance Company Ltd board to consider Q2, H1FY22 results on Oct 19, 2021

A F Enterprises Ltd board to consider conversion of warrants on Sep 30, 2021

ICRA upgrades rating of Indian Metals and Ferro Alloys Ltd

Bharat Forge Limited - The First Indian Company to Achieve Nadcap® Accreditation for Metallic Materials Manufacturing

ICRA upgrades ratings of IDBI Bank

Aditya Vision Ltd opens 73rd showroom

TCS Recognized as a Leader in Procurement Outsourcing by Everest Group

Athena Global Technologies Subsidiary MedleyMed Enters the Global Market with a Suite of Digital Solutions for Both Pharmacy and Patient Care

Adani Airport Holdings Ltd signs SSA with AMRPL for operating duty free outlets

Orient Paper & Industries Ltd reappoints MD

Pondy Oxides & Chemicals Ltd commences trial production of copper recycling

Cyient achieves Select Tier Status in the AWS Partner Network with its evolving expertise in Digital Transformation solutions

SBI Signs SLA with Paisalo Digital for engagement as National Business Correspondent

Intellect launches Capital Cube 21, a Contextual Treasury Platform fueled by Composable Next Gen Technology

IndusInd Bank spreads joy among underprivileged children this festive season

Rare Asset Reconstruction Ltd acquires financial assets of Impex Ferro Tech Limited from SBI

WardWizard Innovations & Mobility Ltd. to double the production capacity by October 2021

InterGlobe Technology Quotient and EaseMyTrip announce agreement worth $10 million

Birlasoft Solution achieves Oracle Validated Integration with JD Edwards EnterpriseOne Expertise for Delivering Proven, Repeatable Integration

Gokul Agro Resources Limited wins Globoil Rising Star of the Year 2021 award

Nucleus Software's PaySe passes RBI's Regulatory Sandbox

Ind-Ra upgrades rating of Happiest Minds Technologies Ltd

Kreon Finnancial Services Ltd updates on business performance

IndusInd Bank partners with Vistara to launch a co-branded credit card

Patel Engineering bags new order of Rs. 1251 crore Teesta-VI Hydro Electric Project

Renaissance Global establishes Strategic Advisory Board

Mindtree Recognized by Great Place to Work® as one of India's Best Workplaces™ for Women 2021

Manali Petrochemical Ltd to partner with Econic, UK for new Polyol Technology

Goa Carbon Ltd shuts down Bilaspur Unit, Goa Unit for maintenance work

Government of India announces India's airspace map for Drones operations

Astrazeneca Pharma India Ltd receives import and market permission for Selumetinib 10 Mg & 25 Mg Capsule

Spirit of Wipro Run brings together participants from 35 countries


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020